Literature DB >> 16288036

Kisspeptin-10-induced signaling of GPR54 negatively regulates chemotactic responses mediated by CXCR4: a potential mechanism for the metastasis suppressor activity of kisspeptins.

Jean-Marc Navenot1, Zixuan Wang, Michael Chopin, Nobutaka Fujii, Stephen C Peiper.   

Abstract

The product of the KiSS-1 gene is absent or expressed at low level in metastatic melanoma and breast cancer compared with their nonmetastatic counterparts. A polypeptide derived from the KiSS-1 product, designated kisspeptin-10 (Kp-10), activates a receptor coupled to Galphaq subunits (GPR54 or KiSS-1R). To study the mechanism by which Kp-10 antagonizes metastatic spread, the effect on CXCR4-mediated signaling, which has been shown to direct organ-specific migration of tumor cells, was determined. Kp-10 blocked chemotaxis of tumor cells expressing CXCR4 in response to low and high concentrations of SDF-1/CXCL12 and inhibited mobilization of calcium ions induced by this ligand. Pretreatment with Kp-10 did not induce down-modulation of cell surface CXCR4 expression, reduce affinity for SDF-1/CXCL12, or alter Galphai subunit activation stimulated by this ligand. Although Kp-10 stimulated prolonged phosphorylation of extracellular signal-regulated kinase 1/2, it inhibited the phosphorylation of Akt induced by SDF-1. The ability of Kp-10 to inhibit signaling and chemotaxis induced by SDF-1 indicates that activation of GPR54 signaling may negatively regulate the role of CXCR4 in programming tumor metastasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288036     DOI: 10.1158/0008-5472.CAN-05-1757

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin receptor nomenclature, distribution, and function.

Authors:  Helen R Kirby; Janet J Maguire; William H Colledge; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 2.  KISS1 in breast cancer progression and autophagy.

Authors:  Ilya V Ulasov; Anton V Borovjagin; Peter Timashev; Massimo Cristofanili; Danny R Welch
Journal:  Cancer Metastasis Rev       Date:  2019-09       Impact factor: 9.264

3.  ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category.

Authors:  Klaus H Metzeler; Heiko Becker; Kati Maharry; Michael D Radmacher; Jessica Kohlschmidt; Krzysztof Mrózek; Deedra Nicolet; Susan P Whitman; Yue-Zhong Wu; Sebastian Schwind; Bayard L Powell; Thomas H Carter; Meir Wetzler; Joseph O Moore; Jonathan E Kolitz; Maria R Baer; Andrew J Carroll; Richard A Larson; Michael A Caligiuri; Guido Marcucci; Clara D Bloomfield
Journal:  Blood       Date:  2011-10-26       Impact factor: 22.113

4.  A high-throughput small-molecule ligand screen targeted to agonists and antagonists of the G-protein-coupled receptor GPR54.

Authors:  Wendy Kuohung; Maria Burnett; Deepa Mukhtyar; Eli Schuman; Jake Ni; William F Crowley; Marcie A Glicksman; Ursula B Kaiser
Journal:  J Biomol Screen       Date:  2010-05-10

Review 5.  Kisspeptins and the placenta: regulation of trophoblast invasion.

Authors:  Ursula Hiden; Martin Bilban; Martin Knöfler; Gernot Desoye
Journal:  Rev Endocr Metab Disord       Date:  2007-03       Impact factor: 6.514

6.  Clinical and biological significance of KISS1 expression in prostate cancer.

Authors:  Honghe Wang; Jacqueline Jones; Timothy Turner; Qinghua P He; Shana Hardy; William E Grizzle; Danny R Welch; Clayton Yates
Journal:  Am J Pathol       Date:  2012-01-06       Impact factor: 4.307

7.  KiSS1 suppresses TNFalpha-induced breast cancer cell invasion via an inhibition of RhoA-mediated NF-kappaB activation.

Authors:  Sung-Gook Cho; Dali Li; Lewis J Stafford; Jian Luo; Melissa Rodriguez-Villanueva; Ying Wang; Mingyao Liu
Journal:  J Cell Biochem       Date:  2009-08-15       Impact factor: 4.429

Review 8.  KISS1 in metastatic cancer research and treatment: potential and paradoxes.

Authors:  Thuc Ly; Sitaram Harihar; Danny R Welch
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

Review 9.  Metastasis suppressors and their roles in breast carcinoma.

Authors:  Kedar S Vaidya; Danny R Welch
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-09       Impact factor: 2.673

10.  Astrocytes promote progression of breast cancer metastases to the brain via a KISS1-mediated autophagy.

Authors:  Natalya Kaverina; Anton V Borovjagin; Zaira Kadagidze; Anatoly Baryshnikov; Maria Baryshnikova; Dmitry Malin; Dhimankrishhna Ghosh; Nameeta Shah; Danny R Welch; Patrik Gabikian; Apollon Karseladze; Charles Cobbs; Ilya V Ulasov
Journal:  Autophagy       Date:  2017-10-05       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.